Tarsadia Investments

Tarsadia Investments is a multibillion-dollar, multi-strategy private investment management vehicle and family office. It invests across venture and growth equity, life sciences, real estate, financial services, technology, and commodities. The firm has over $2B in assets under management and a dedicated life sciences strategy focused on drug delivery technologies and preclinical and early clinical-stage assets in CNS, inflammation/immunology, oncology, and biosimilars. It typically invests $5M–$75M and often leads rounds, positioning itself as a long-duration, high-conviction partner to category-defining companies, especially in healthtech, fintech, and deep tech.